Drug maker Johnson & Johnson (NYSE: JNJ) is all set to embark on an extensive program to strengthen the product portfolio and
Search Results for: Johnson & Johnson
Johnson & Johnson Q1 earnings slide on flat revenue growth
Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16, before the
Earnings preview: Johnson & Johnson (JNJ) to stay buoyant in Q1 despite challenges
Johnson & Johnson (NYSE: JNJ), one of the first healthcare companies to publish quarterly results this season, will be reporting March-quarter results
Johnson & Johnson buys Auris Health to boost medical devices business
Establishing its foray into robotic health products, pharmaceutical giant Johnson & Johnson (JNJ) on Wednesday announced it was acquiring California-based Auris Health
Johnson & Johnson Q4 Earnings: stellar pharma sales help deliver upbeat results
Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings for the fourth-quarter as it posts higher-than-expected quarterly results on January 22,
Earnings Preview: Will the talc debacle devour Johnson & Johnson in Q4?
Healthcare giant Johnson & Johnson (JNJ) will kick off pharma earnings for the fourth-quarter as it posts its quarterly and full year
Johnson & Johnson dips on revenue decline in India
Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in the year
Johnson & Johnson will spend more time in court in 2019
The tainted talc has been snowballing into a gigantic threat since 2016, and things are not looking good as Johnson & Johnson
Pharmaceuticals unit lifts Johnson & Johnson results in Q3
Medical devices giant Johnson & Johnson (JNJ) reported higher revenue and income in Q3, driven by strong sales of pharmaceuticals products. The
Johnson & Johnson under the scanner in India over “faulty” hip replacement devices
An experts’ panel framed by India’s Ministry of Health has found that Johnson & Johnson (JNJ) suppressed facts relating to its “faulty”
Cancer drugs lift Johnson & Johnson’s sales in Q1
Pharmaceutical giant Johnson & Johnson (JNJ) reported a 12.6% increase in sales to $20 billion for the first quarter of 2018 as
Will biosimilars play spoilsport in Johnson & Johnson earnings?
Pharmaceutical giant Johnson & Johnson’s (JNJ) earnings results are due on April 17 before the opening bell, amidst concerns over the rising
Is Johnson & Johnson a ‘sell’ in 2018?
Johnson & Johnson may not be having a great 2018 so far with the stock ticking down about 8% since the year
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call dated Oct. 17, 2023 Corporate Participants: Jessica Moore -- Vice President - Investor
Johnson & Johnson (JNJ) Q1 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J.
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2022 earnings call dated Jan. 24, 2023 Corporate Participants: Jessica Moore -- Vice President of Investor Relations Joaquin
Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joaquin Duato -- Chief
Johnson & Johnson (JNJ) Q1 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2022 earnings call dated Apr. 19, 2022 Corporate Participants: Joseph J. Wolk -- Executive Vice President, Chief Financial
Johnson & Johnson (JNJ) Q4 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J. Wolk -- Executive